PRESS RELEASE published on 07/26/2024 at 18:30, 3 months 25 days ago EssilorLuxottica: Publication of the 2024 Interim Financial Report EssilorLuxottica publishes 2024 Interim Financial Report, includes Management Report, Financial Statements, and Auditor's Review. Download from website Financial Statements Investors EssilorLuxottica 2024 Interim Financial Report Ophthalmic Lenses
BRIEF published on 06/18/2024 at 18:50, 5 months 2 days ago EssilorLuxottica and Diesel announce 10-year licensing agreement Diesel Fashion License Agreement EssilorLuxottica Glasses
PRESS RELEASE published on 06/18/2024 at 18:45, 5 months 2 days ago EssilorLuxottica and Diesel announce a ten-year licensing agreement EssilorLuxottica and Diesel announce a 10-year licensing agreement for Diesel eyewear. The first collection under the deal will be available in Q1 2025, combining Diesel's style with EssilorLuxottica's craftsmanship Licensing Agreement Collaboration Diesel Eyewear EssilorLuxottica
Published on 11/21/2024 at 13:30, 24 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 24 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 54 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 54 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 54 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 19 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 39 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 56 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 34 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
